In prostate cancer, PTBP1 was known to affect the clinical response to Androgen-deprivation therapy [36], indicting PTBP1 plays vitally regulatory roles in clinical cancer diagnosis and treatment. This evidence concerns the gene PTBP1 and Familial prostate cancer.